ivci:cis

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
ivci:cis [2023/09/03 12:52] fkaagivci:cis [2024/08/13 10:16] (current) – [Maintained] lbourges
Line 2: Line 2:
 ====== Code CIS ====== ====== Code CIS ======
 <data Code> <data Code>
-Complete : 20+Complete : 16
 Precise : 100 Precise : 100
-Informative:+License [enum::license]: 50 
-Tolerant [enum::Tolerant]: 50 +Maintained [enum::Maintenance]: 100
-Inclusive: +
-Mappable [enum::Mappable]: 50 +
-License: +
-Maintained:+
 </data> </data>
 +===== Diagram=====
 +<radar ?complete ?precise ?license ?maintained>
 +[[]] complete: ?complete
 +[[]] precise: ?precise
 +[[]] license: ?license
 +[[]] maintained: ?maintained
 +</radar>
 +===== Overview =====
 Each country has its own set of pharmaceutical codes for medicines, such as CIS in France, CNK in Belgium, PZN in Germany, etc.  It is generally complemented with presentation codes, that identify the packaged product. Ultimately, the EU pharmaceutical codes will be superseded by the Products facet of the SPOR database, encoded in IDMP, and curated by the EMA. Each country has its own set of pharmaceutical codes for medicines, such as CIS in France, CNK in Belgium, PZN in Germany, etc.  It is generally complemented with presentation codes, that identify the packaged product. Ultimately, the EU pharmaceutical codes will be superseded by the Products facet of the SPOR database, encoded in IDMP, and curated by the EMA.
  
 The evaluation of metrics is done against CIS, the French pharmaceutical code system for products. The codes from other countries or the future SPOR product code would give similar results. The evaluation of metrics is done against CIS, the French pharmaceutical code system for products. The codes from other countries or the future SPOR product code would give similar results.
-====== Complete ====== +===== Complete ===== 
-The CIS codification was initiated in 1972Only products authorised in France are encoded. +Computed on NUVA version 1.0.740 using [[nuva-utils]] with the alignments built in [[NUVA]]
-For the time being, the CIS database contains 243 codes for vaccine products. It results in an exhaustiveness index of 20%. +===== Precise ===== 
- +Computed on NUVA version 1.0.740 using [[nuva-utils]] with the alignments built in [[NUVA]].
-====== Precise ====== +
-Pharmaceutical codes identify products without any ambiguity, the unambiguousness index is at 100%. +
- +
-====== Informative ====== +
-Pharmaceutical codes are only lists of codes and labels; they do not carry any codified information about the product natureHence their informativeness index is 0%. +
- +
-====== Tolerant ====== +
-Only a single label, with a very formalized structure, is associated with each code. Matching will only be possible with this label, meaning a paper trail inclusiveness of 50%. +
- +
-====== Inclusive ====== +
-There is generally a structural correspondence between pharmaceutical codes and their packaged product codes. Apart from that, no transcription is proposed for other code systems. The inclusiveness for digital trails is thus valued at 1/50 = 2%. +
- +
-====== Mappable ====== +
-By itself, the codification does not carry any resource for translation to other codes. Technically, translation to pharmaceutical codes of other countries will be possible. Generally, the associated ATC code for the substance can also be found by looking up in public databases. The translatability index is thus set at 50%.+
  
 ====== Open-licensed ====== ====== Open-licensed ======
Line 37: Line 27:
 ====== Maintained ====== ====== Maintained ======
  
 +====== Resources ======
  
 +{{ :ivci:nuva_refcode_cis.csv |}}
  
  
  • ivci/cis.1693745550.txt.gz
  • Last modified: 2023/09/03 12:52
  • by fkaag